U.S. Seeks to Pause J&J Covid-19 Vaccine Use Amid Clotting Reports
April 13 2021 - 7:56AM
Dow Jones News
By Michael Wright
U.S. health authorities recommended a pause in the use of
Johnson & Johnson's Covid-19 vaccine after reports of rare
blood clotting in recipients of the shot based in the U.S.
The Food and Drug Administration said in a tweet Tuesday that it
and the Centers for Disease Control and Prevention were reviewing
data involving six reported cases of clotting.
The FDA said it was recommending a pause in the use of the
J&J vaccine "out of an abundance of caution."
(END) Dow Jones Newswires
April 13, 2021 07:41 ET (11:41 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2023 to Apr 2024
